Matches in Wikidata for { <http://www.wikidata.org/entity/Q104289686> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q104289686 description "2020 ވަނަ އަހަރުގެ ޑިސެމްބަރުމަހުގެ 9ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q104289686 description "artículu científicu espublizáu n'avientu de 2020" @default.
- Q104289686 description "scientific article published on 09 December 2020" @default.
- Q104289686 description "wetenschappelijk artikel" @default.
- Q104289686 description "наукова стаття, опублікована 9 грудня 2020" @default.
- Q104289686 name "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 name "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 name "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 type Item @default.
- Q104289686 label "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 label "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 label "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 prefLabel "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 prefLabel "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 prefLabel "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 P1433 Q104289686-1DAF2E70-0AE2-486B-822F-8401765E44F0 @default.
- Q104289686 P1476 Q104289686-EBC8801A-6AFD-49F1-970C-1C29C54D5F32 @default.
- Q104289686 P2093 Q104289686-757B5E03-CFA9-4F85-90B7-3B5E87DB59D6 @default.
- Q104289686 P2093 Q104289686-E450300F-AD25-4E71-B439-4FC72C47D430 @default.
- Q104289686 P31 Q104289686-38EAD806-9978-4E92-852E-ED141719CED6 @default.
- Q104289686 P356 Q104289686-B0120CDF-B599-4868-AF8F-0311AED35B98 @default.
- Q104289686 P577 Q104289686-4FE24C09-F25D-4C96-80E4-942FC51B498B @default.
- Q104289686 P698 Q104289686-02A516F1-AC01-4615-A332-E98914F0CD1E @default.
- Q104289686 P921 Q104289686-6DFFB9AB-1DE4-40C2-96F4-794B49FD4282 @default.
- Q104289686 P921 Q104289686-C4517ABB-8AC0-4C4D-A9A5-F0DF5357EBDA @default.
- Q104289686 P356 J.ANNONC.2020.12.001 @default.
- Q104289686 P698 33309745 @default.
- Q104289686 P1433 Q326122 @default.
- Q104289686 P1476 "Effectiveness of Rituximab in treating Immune Checkpoint Inhibitor-Induced immune-related Adverse Events: Results of a Systematic Review" @default.
- Q104289686 P2093 "D Georgonikou" @default.
- Q104289686 P2093 "S N Deftereos" @default.
- Q104289686 P31 Q13442814 @default.
- Q104289686 P356 "10.1016/J.ANNONC.2020.12.001" @default.
- Q104289686 P577 "2020-12-09T00:00:00Z" @default.
- Q104289686 P698 "33309745" @default.
- Q104289686 P921 Q1504425 @default.
- Q104289686 P921 Q412323 @default.